Other functions anti muellerian-hormone levels and ovarian cancer risk in the janus biobank
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201200394P
- Awardee
-
Oslo Universitetssykehus HF UEI T56MFRK2AUJ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $56,903
Award facts
- Opportunity
-
- NCI120133TG Solicitation number
- Anti-Muellerian-Hormone levels and ovarian cancer risk in the JANUS biobank Award Notice · Posted Jul 27, 2012
- Contract value 100% obligated
- $56,903.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Norway
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $56,903 |
Quick answers
Who was awarded contract HHSN261201200394P?
HHSN261201200394P was awarded to Oslo Universitetssykehus HF by National Cancer Institute (National Institutes of Health) on September 25, 2012.
How much is contract HHSN261201200394P worth?
The government has obligated $56,903 on HHSN261201200394P.
Was contract HHSN261201200394P competed?
The extent of competition for HHSN261201200394P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award